Global Cord Blood (Global Cord Blood) Net Margin % : 35.23% (As of Mar. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Global Cord Blood Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Global Cord Blood's Net Income for the three months ended in Mar. 2022 was $16.5 Mil. Global Cord Blood's Revenue for the three months ended in Mar. 2022 was $46.8 Mil. Therefore, Global Cord Blood's net margin for the quarter that ended in Mar. 2022 was 35.23%.

The historical rank and industry rank for Global Cord Blood's Net Margin % or its related term are showing as below:

CORBF's Net Margin % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -11.145
* Ranked among companies with meaningful Net Margin % only.

Global Cord Blood Net Margin % Historical Data

The historical data trend for Global Cord Blood's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Cord Blood Net Margin % Chart

Global Cord Blood Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Net Margin %

Get a 7-Day Free Trial

25.31

29.50

38.54

43.83

40.30

Global Cord Blood Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Net Margin %	Get a 7-Day Free Trial															42.25	43.28	40.09	42.31	35.23

Competitive Comparison of Global Cord Blood's Net Margin %

For the Diagnostics & Research subindustry, Global Cord Blood's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Cord Blood's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's Net Margin % distribution charts can be found below:

* The bar in red indicates where Global Cord Blood's Net Margin % falls into.

Global Cord Blood Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Global Cord Blood's Net Margin for the fiscal year that ended in Mar. 2022 is calculated as

Net Margin	=	Net Income (A: Mar. 2022 )	/	Revenue (A: Mar. 2022 )
	=	78.975	/	195.955
	=	40.30 %

Global Cord Blood's Net Margin for the quarter that ended in Mar. 2022 is calculated as

Net Margin	=	Net Income (Q: Mar. 2022 )	/	Revenue (Q: Mar. 2022 )
	=	16.505	/	46.844
	=	35.23 %

Global Cord Blood (OTCPK:CORBF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Global Cord Blood Net Margin % Related Terms

Thank you for viewing the detailed overview of Global Cord Blood's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Cord Blood (Global Cord Blood) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Global Cord Blood Corp (OTCPK:CORBF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG

Website

http://www.globalcordbloodcorp.com

Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.

Executives

Kent C Mccarthy	10 percent owner, other: Mbr 13(d) grp own 10% plus	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Fund Ii Lp	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
7-2010 Grat 5 Under Kent C. Mccarthy Grat Tr Dtd 4-23-2010	other: 13 (d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
7-2010 Grat 6 Under Kent C Mccarthy Grat Tr Dtd 4-23-2010	10 percent owner, other: Member of 13(d) group owning m	7335 COTTONWOOD, SHAWNEE KS 66216
Mccarthy Family Sd, Llc	10 percent owner, other: 13 (d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Fund Ii, Llc	other: 13(d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Management Ii, Llc	other: 13(d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jcf Co Lf, L.p.	other: 13(d) group owning > 10%	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Capital Management Llc	other: Member of the group	13021 W 74TH ST, SHAWNEE KS 66216
Jayhawk China Fund Cayman Ltd	other: Member of the group	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Gp Ii, L.p.	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
Jayhawk Private Equity, Llc	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205